Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not measurably improve glucose tolerance or beneficially alter the gut microbiome in sedentary adults with overweight or obesity. While animal research...
Cannabinoid Clinical Trials: CBD, Glucose & Gut Health
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not produce measurable improvements in glucose tolerance, gut microbiome composition, or inflammatory markers in sedentary adults with overweight or obesity. While...
Cannabinoid Clinical Trials: CBD, Glucose & Gut Health
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not improve glucose tolerance, gut microbiome composition, or inflammatory markers in sedentary adults with overweight or obesity. While animal studies and...
endocannabinoid system clinical research: CBD & Metabolic Health
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not produce measurable improvements in glucose tolerance, gut microbiome composition, or inflammation markers in sedentary adults with overweight or obesity. While...
Cannabidiol & Glucose Tolerance: Clinical Research Review
Clinical Takeaway In this pilot study, short-term low-dose oral CBD did not produce measurable improvements in glucose tolerance, gut microbiome composition, or inflammatory markers in sedentary adults with overweight or obesity. While...
endocannabinoid system clinical research: CBD & Metabolism
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not produce measurable improvements in glucose tolerance, gut microbiome composition, or inflammation markers in sedentary adults with overweight or obesity. While...